logo
History buff uncovers lost medieval monastery thanks to strange map symbol

History buff uncovers lost medieval monastery thanks to strange map symbol

Fox News3 days ago

A history buff with a metal detector recently led archaeologists to the site of a medieval monastery – all thanks to a strange symbol spotted on an old map.
Arkeologerna, an archaeological organization affiliated with the Swedish government, announced the discovery this month. The remains of the monastery were found in a field in Derome, in southwest Sweden.
In a statement translated from Swedish to English, Arkeologerna credited hobbyist Göran Bengtsson with pinpointing the site.
While studying 18th-century maps, Bengtsson noticed a strange rectangle — and brought himself to the site. A surveyor marked the location as "Klosterkullen," or "monastery hill," on a 1760 map.
After an alert from Bengtsson, archaeologists headed out to the location to use ground-penetrating radar (GPR) to scope out the site. GPR can show things hidden in the ground — and it revealed the walls of "probable" monastery ruins.
Archaeologist Bengt Westergaard said the find came as a total surprise to him.
"I have worked as an archaeologist for 40 years, and this is something unique," Westergaard said.
He added, "I have never seen anything like it; the walls were very clearly visible."
"I have never seen anything like it."
The weather conditions helped archaeologists, too. Bengtsson found traces of the monastery on a dry summer day.
"When the ground is dry, something called crop marks can form, and these walls are very visible above ground," he explained.
"When using ground-penetrating radar, any structures below ground appear as dark spots, and here there was a significant anomaly."
Archaeologists uncovered walls which are roughly 6.5 feet thick, as well as other facets of the building.
Experts believe the walls were remains of pillar foundations.
"It is the eastern wing and dormitory we see," Arkeologerna's statement added. "It is not certain that more was built; they may have started building the church and then stopped."
"We won't know until we investigate the site further."
Dating back to the late 1100s, the monastery might be the original site of Ås Abbey, a large monastery managed by the Cistercian religious order.
"Ås … was later moved in the 13th century," the statement continued. "In a letter from a meeting in 1243, the then-abbot applied to move Ås monastery."
Sweden, a Nordic country rich in history, has been home to several historical discoveries in the past year.
Last spring, archaeologists uncovered a 12th century grave during a dig – and found buried treasure along with it.
This year, Arkeologerna announced the discovery of an "unusual" Viking-era coffin dating back over 1,100 years.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

BPC Instruments receives orders from KU Leuven valued at 0.7 MSEK
BPC Instruments receives orders from KU Leuven valued at 0.7 MSEK

Yahoo

time3 hours ago

  • Yahoo

BPC Instruments receives orders from KU Leuven valued at 0.7 MSEK

LUND, Sweden, June 4, 2025 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") announces orders from KU Leuven university in Belgium. The orders include the delivery of several instruments, including Gas Endeavour® III systems, with a combined value of approximately 0.7 MSEK. CEO Dr. Jing Liu comments: "We are pleased to receive a significant order from a globally recognised research institution. KU Leuven's decision to transition to our technology confirms the value and reliability of our instruments in advanced scientific applications." BPC has received orders from university KU Leuven in Belgium. The value of the orders amounts to approximately 0.7 MSEK and includes several instruments including Gas Endeavour® III. The university is replacing and upgrading its setup for biochemical methane potential (BMP) testing with BPC's instruments for both batch and continuous measurements. The new systems are expected to streamline workflows and provide more precise and reliable data in research related to biological and biochemical gas processes. Revenue from these orders is expected to be recognised in Q2 2025. About Gas Endeavour® III Gas Endeavour® III is an advanced laboratory instrument platform designed for precise evaluation of gas production or consumption measurements in both batch and continuous processes. With its fully automated operation, an intuitive user interface, and high reliability, it offers exceptional ease of use. The system is available with 18 or 9 parallel channels, allowing for the simultaneous evaluation of multiple samples. For more information about Gas Endeavour® III, visit the Gas Endeavour® III product page or contact the sales team at sales@ For more information, please contact: Dr. Jing Liu, CEOBPC Instruments AB Tel: +46 (0) 46 16 39 51 E-mail: ir@ About BPC Instruments AB BPC Instruments is a global Swedish-based pioneering technology company developing and offering analytical instruments enabling more efficient, reliable, and higher quality research and analysis for industries in renewable bioenergy and environmental biotechnology. The result is not only higher accuracy and precision, but also a significant reduction in time consumption and labor requirement for performing analysis. BPC Instruments' innovative products offer high-quality hardware and software based on deep knowledge and experience of target applications. The solutions are the first of their kind, making the company a pioneer in its field. Today, BPC Instruments exports to nearly 80 countries around the world. BPC is listed on the Spotlight Stock Market in Sweden. For more information, please visit BPC's webpage: This information was brought to you by Cision The following files are available for download: Press release - KU Leuven View original content:

AlzeCure Pharma to present at Redeye Investor Forum on June 11
AlzeCure Pharma to present at Redeye Investor Forum on June 11

Yahoo

time4 hours ago

  • Yahoo

AlzeCure Pharma to present at Redeye Investor Forum on June 11

STOCKHOLM, SE / / June 4, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the company will participate at Redeye Investor Forum Stockholm on June 11 at 14:35 CET, where CEO Martin Jönsson will give a company presentation and answer questions about the latest developments and Alzecure's future plans. Watch the livestream via The session will also be available after the event on AlzeCure's company page at Redeye , and on AlzeCure's website . Time & date: 14:35 CET, June 11, 2025Venue: Redeye, Mäster Samuelsgatan 42, Stockholm, Sweden For more information, please contact Martin Jönsson, CEOTel: +46 707 86 94 About AlzeCure Pharma AB (publ) AlzeCure ® is a Swedish pharmaceutical company that develops new innovative drug therapies for the treatment of severe diseases and conditions that affect the central nervous system, such as Alzheimer's disease and pain - indications for which currently available treatment is very limited. The company is listed on Nasdaq First North Premier Growth Market and is developing several parallel drug candidates based on three research platforms: NeuroRestore ® , Alzstatin ® and Painless. NeuroRestore consists of two symptomatic drug candidates where the unique mechanism of action allows for multiple indications, including Alzheimer's disease, as well as cognitive disorders associated with traumatic brain injury, sleep apnea and Parkinson's disease and is being prepared for phase 2. The Alzstatin platform focuses on developing disease-modifying and preventive drug candidates for early treatment of Alzheimer's disease. Painless is the company's research platform in the field of pain and contains two projects: ACD440, which is a drug candidate in the clinical development phase for the treatment of neuropathic pain with positive phase 2 results, and TrkA-NAM, which targets severe pain in conditions such as osteoarthritis. AlzeCure aims to pursue its own projects through preclinical research and development through an early clinical phase, and is continually working on business development to find suitable outlicensing solutions with other pharmaceutical companies. FNCA Sweden AB is the company's Certified Adviser. For more information, please visit . Image Attachments Martin Jönsson CEO AlzeCure Pharma Attachments AlzeCure Pharma to present at Redeye Investor Forum on June 11 SOURCE: AlzeCure Pharma View the original press release on ACCESS Newswire Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Ancient DNA reveals how Mayan civilisation collapsed
Ancient DNA reveals how Mayan civilisation collapsed

Yahoo

time5 hours ago

  • Yahoo

Ancient DNA reveals how Mayan civilisation collapsed

Skeletons unearthed from the ruins of the ancient city of Copán in Honduras have yielded clues to the collapse of the Mayan civilisation. Copán, now a Unesco World Heritage site, thrived during the Classic Maya period between the third and 10th centuries AD. Previous research has shown that it was a major crossroads city for four centuries, connecting the lower Central America to South America. 'In 426 or 427CE, the city witnessed the establishment of a royal dynasty, which endured for about 400 years,' according to a new study published in the journal Current Biology. Excavations at the ruins have so far focused on a royal tomb where rulers were likely buried along with sacrificial victims. But the genetic origins of the people of ancient Copán have been unclear. The new genome study shows where this population most likely came from and reveals the city 'dramatically shrank' around 1,200 years ago. Researchers assessed genomes of seven human remains excavated at the Copán archaeological site, including a person who may have been the ancient city's ruler. The analysis also included DNA data from ancient Mayan sites in North, Central, and South America that have already been published in previous studies. It revealed, for the first time, the origins and dynamics of the ancient city's population during the Classic period, shedding more light on the civilisation's collapse. It found that the ancestral population of the Copan people interacted with northern regions, including those in Mexico and Belize. That the Maya people had connections with those in the central highlands of Mexico had only been theorised in the past. The analysis also pointed to a strong genomic connection of the people of the Copán ruins with modern Maya, including the contemporary populations in the Andes, Brazil, and Argentina. Another key finding from the study is that the population size of the Maya civilisation decreased vastly during the late Classic period. This result corresponds to the period when other Classic Maya cities were also abandoned, researchers said. 'A decline is also observable in the Andes at around the same time. Nevertheless, the population size in the Andes rebounded in later periods, possibly linked to the rise and expansion of the Inca civilisation,' they said. A decline in the population density led to the eventual collapse of the Classic Maya civilisation, they concluded. This was between the 9th and 11th centuries, a period marked by frequent severe droughts that contributed to civil conflict, societal instability, and eventual collapse. 'Estimates of effective population size suggest a decline at the end of the Classic period, when Classic Maya civilisation experienced widespread destabilisation and collapse,' the study noted.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store